Andrew Orth

Money Moves

Led City through its October 2026 IPO, which closed at $230 million gross

City Therapeutics closed its upsized Nasdaq IPO on October 19, raising $230 million before fees after underwriters bought all 1.67 million extra shares. The Cambridge biotech sold 12.8 million shares at $18 each. Its stock rose about 24% in its October 16 debut.

Updated Oct 21